Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Vitex trifolia, also known as the three-leaved chaste tree, is a medicinal shrub used traditionally in Eastern Asia and the Pacific to treat inflammation, headaches, and fever [PMID:36822343, PMID:38576489, PMID:35866139].
Contexte
Vitex trifolia L. is a medicinal and ornamental shrub in the Lamiaceae (or Verbenaceae) family, widely distributed from East Africa to the Pacific [PMID:35866139, PMID:38576489]. Its dried ripe fruits are known in Traditional Chinese Medicine as Viticis Fructus or Manjingzi [PMID:37810114, PMID:32237401].
Usages traditionnels
Traditionally used to treat headaches, fever, diarrhea, hair loss, wound recovery [PMID:36822343], rhinitis, dizziness [PMID:32188443], rheumatic pain [PMID:32188443], colds, vertigo, anesthesia, and hyperkinesias [PMID:37810114]. It is also used for liver protection in Myanmar [PMID:31878261].
Composés actifs
Phytochemical analyses have identified terpenoids (including labdane and abietane diterpenes), flavonoids (such as vitexicarpin), lignans (such as (-)-O-methylcubebin and vitexilactone), phytosterols (beta-sitosterol, beta-daucosterol), anthraquinones, fatty acids, and iridoid derivatives [PMID:38576489, PMID:25272835, PMID:29429059, PMID:35777590, PMID:40520165, PMID:31878261, PMID:29165364, PMID:37842907, PMID:11140517].
Mécanisme d'action
Vitex trifolia leaf extracts modulate inflammatory mediators by down-regulating the NF-κB signaling pathway and inhibiting the nuclear translocation of NF-κB [PMID:36028166, PMID:22732725]. The flavonoid vitexicarpin acts as a selective inhibitor of Anoctamin 1 (ANO1), a calcium-activated chloride channel [PMID:40520165]. Certain constituents like vitexilactone and (-)-O-methylcubebin may enhance adipogenesis via PPARγ activation and inhibition of ERK1/2 and p38MAPK phosphorylation [PMID:31878261, PMID:29165364].
Preuves cliniques
Preuve DAcute Inflammation
Methanolic leaf extract reduced paw edema and modulated inflammatory cytokines in experimental rats [PMID:36028166]
Preuve DHepatotoxicity (CCl4-induced)
Aqueous and ethanol leaf extracts significantly reduced total bilirubin and serum marker enzymes (ALT, AST, ALP) and increased total protein in animal models [PMID:20046723]
Preuve DBacterial Infections
Leaf extracts showed moderate inhibiting activity against gram-positive and gram-negative bacteria [PMID:11543973]; specific iridoid derivatives showed activity against E. faecalis, S. aureus, E. coli, and P. aeruginosa [PMID:37842907]
Preuve DMycobacterium tuberculosis
Specific diterpenoids (9-hydroxy-13(14)-labden-15,16-olide and isoambreinolide) exhibited antitubercular activity [PMID:23462211]
Preuve DCancer (CRC and NSCLC)
Vitexicarpin reduced cancer cell viability and induced apoptosis in colorectal and non-small cell lung cancer cell lines [PMID:40520165]
Preuve D
Sécurité et effets indésirables
Vitexicarpin exhibited minimal hepatotoxicity and negligible hERG channel inhibition in cell line studies [PMID:405201 la65].
Synthèse des preuves
The current evidence is primarily based on in vitro studies and animal models (Level D) and literature reviews (Level C). There are no reported human clinical trials (RCTs) in the provided abstracts.
Sources PubMed
1.PMID: 36822343 (2023) — Vitex rotundifolia L. f. and Vitex trifolia L.: A review on their traditional medicine, phytochemistry, pharmacology. · Journal of ethnopharmacology
2.PMID: 38576489 (2024) — A comprehensive review of ethnomedicinal approaches, phytochemical analysis, and pharmacological potential of Vitex trifolia L. · Frontiers in pharmacology
3.PMID: 35866139 (2022) — The complete chloroplast genome of Vitex trifolia L. (Lamiaceae). · Mitochondrial DNA. Part B, Resources
4.PMID: 26756820 (2016) — Identification of New Diterpenes as Putative Marker Compounds Distinguishing Agnus Castus Fruit (Chaste Tree) from Shrub Chaste Tree Fruit (Viticis Fructus). · Planta medica
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
Labdane diterpenoids from fruits exhibited moderate inhibitory activities against α-glucosidase [PMID:35777590]
— Vitex trifolia L. modulates inflammatory mediators via down-regulation of the NF-κB signaling pathway in carrageenan-induced acute inflammation in experimental rats.
· Journal of ethnopharmacology
6.PMID: 37810114 (2023) — Traditional use, phytochemistry and pharmacology of Viticis Fructus. · Heliyon
8.PMID: 32188443 (2020) — Effects of Vitex trifolia L. leaf extracts and phytoconstituents on cytokine production in human U937 macrophages. · BMC complementary medicine and therapies
9.PMID: 25272835 (2014) — Chemical of Vitex trifolia. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
10.PMID: 29429059 (2018) — Terpenoids from Vitex trifolia and their anti-inflammatory activities. · Journal of natural medicines
11.PMID: 35777590 (2022) — Diterpenoids with α-glucosidase inhibitory activities from the fruits of Vitex trifolia Linn. · Fitoterapia
12.PMID: 40520165 (2025) — Vitexicarpin suppresses colorectal and non-small cell lung cancer via selective inhibition of Anoctamin 1. · Frontiers in pharmacology
13.PMID: 40943466 (2025) — Network Pharmacology-Guided Discovery of Traditional Chinese Medicine Extracts for Alzheimer's Disease: Targeting Neuroinflammation and Gut-Brain Axis Dysfunction. · International journal of molecular sciences
14.PMID: 41671880 (2026) — Microbiota-dependent mechanism of Jianpiyifei II in treating experimental virus-induced acute exacerbation of chronic obstructive pulmonary disease. · Phytomedicine : international journal of phytotherapy and phytopharmacology
15.PMID: 37842907 (2023) — Three Undescribed Iridoid Derivatives Isolated from the Fruits of Vitex trifolia with Their Cytotoxic and Antimicrobial Activities. · Chemistry & biodiversity
16.PMID: 42307327 (2026) — Larvicidal and oviposition deterrent activities of Pongamia pinnata (L.) Pierre and Vitex trifolia (L.) leaves extracts against mosquito (Aedes aegypti Linnaeus 1762). · Brazilian journal of biology = Revista brasleira de biologia
17.PMID: 22732725 (2012) — Aqueous extract of Vitex trifolia L. (Labiatae) inhibits LPS-dependent regulation of inflammatory mediators in RAW 264.7 macrophages through inhibition of Nuclear Factor kappa B translocation and expression. · Journal of ethnopharmacology
18.PMID: 31365621 (2019) — Larvicidal activity of essential oil from Vitex negundo and Vitex trifolia on dengue vector mosquito Aedes aegypti. · Revista da Sociedade Brasileira de Medicina Tropical
19.PMID: 11140517 (2000) — Diterpenoids from the fruits of Vitex trifolia. · Phytochemistry
20.PMID: 32734676 (2020) — Comprehensive identification of Vitex trifolia fruit and its five adulterants by comparison of micromorphological, microscopic characteristics, and chemical profiles. · Microscopy research and technique
21.PMID: 31878261 (2019) — (-)-O-Methylcubebin from Vitex trifolia Enhanced Adipogenesis in 3T3-L1 Cells via the Inhibition of ERK1/2 and p38MAPK Phosphorylation. · Molecules (Basel, Switzerland)
22.PMID: 23462211 (2013) — Antitubercular diterpenoids from Vitex trifolia. · Phytomedicine : international journal of phytotherapy and phytopharmacology
23.PMID: 22557139 (2004) — ANTIMICROBIAL POTENTIAL OF VITEX TRIFOLIA Linn. · Ancient science of life
24.PMID: 29165364 (2017) — The Rosiglitazone-Like Effects of Vitexilactone, a Constituent from Vitex trifolia L. in 3T3-L1 Preadipocytes. · Molecules (Basel, Switzerland)
25.PMID: 28953235 (2017) — Comparative Evaluation of Polyphenol Contents and Antioxidant Activities between Ethanol Extracts of Vitex negundo and Vitex trifolia L. Leaves by Different Methods. · Plants (Basel, Switzerland)
26.PMID: 29047177 (2018) — Selected hepatoprotective herbal medicines: Evidence from ethnomedicinal applications, animal models, and possible mechanism of actions. · Phytotherapy research : PTR
27.PMID: 32237401 (2019) — [Herbal textual research on Chinese medicine "Manjingzi"(Viticis Fructus)]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
28.PMID: 30650546 (2019) — A Review on the Phytochemistry, Medicinal Properties and Pharmacological Activities of 15 Selected Myanmar Medicinal Plants. · Molecules (Basel, Switzerland)
29.PMID: 26862271 (2015) — Assessment of Anticarcinogenic Potential of Vitex trifolia and Triticum aestivum Linn by In Vitro Rat Liver Microsomal Degranulation. · Toxicology international
30.PMID: 20046723 (2008) — Hepatoprotective Activity of Vitex trifolia against Carbon Tetrachloride-induced Hepatic Damage. · Indian journal of pharmaceutical sciences